These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. Lee BH, Kwak SH, Shin JI, Lee SH, Choi HJ, Kang HG, Ha IS, Lee JS, Dragon-Durey MA, Choi Y, Cheong HI. Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976 [Abstract] [Full Text] [Related]
5. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Francis NJ, McNicholas B, Awan A, Waldron M, Reddan D, Sadlier D, Kavanagh D, Strain L, Marchbank KJ, Harris CL, Goodship TH. Blood; 2012 Jan 12; 119(2):591-601. PubMed ID: 22058112 [Abstract] [Full Text] [Related]
6. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ. Blood; 2010 Jan 14; 115(2):379-87. PubMed ID: 19861685 [Abstract] [Full Text] [Related]
7. Copy number variation analysis using next-generation sequencing identifies the CFHR3/CFHR1 deletion in atypical hemolytic uremic syndrome: a case report. Park J, Yhim HY, Kang KP, Bae TW, Cho YG. Hematology; 2022 Dec 14; 27(1):603-608. PubMed ID: 35617302 [Abstract] [Full Text] [Related]
8. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Józsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C. Blood; 2008 Feb 01; 111(3):1512-4. PubMed ID: 18006700 [Abstract] [Full Text] [Related]
9. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. Dragon-Durey MA, Blanc C, Marliot F, Loirat C, Blouin J, Sautes-Fridman C, Fridman WH, Frémeaux-Bacchi V. J Med Genet; 2009 Jul 01; 46(7):447-50. PubMed ID: 19435718 [Abstract] [Full Text] [Related]
11. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Würzner R, Jungraithmayr T, German-Austrian HUS Study Group. Clin J Am Soc Nephrol; 2013 Mar 01; 8(3):407-15. PubMed ID: 23243267 [Abstract] [Full Text] [Related]
12. Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication. Tasaki Y, Tsujimoto H, Yokoyama T, Sugimoto N, Kitajima S, Fujii H, Hidaka Y, Kato N, Maruyama S, Inoue N, Wada T. Front Immunol; 2024 Mar 01; 15():1360855. PubMed ID: 38524137 [Abstract] [Full Text] [Related]
13. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Fritsche LG, Lauer N, Hartmann A, Stippa S, Keilhauer CN, Oppermann M, Pandey MK, Köhl J, Zipfel PF, Weber BH, Skerka C. Hum Mol Genet; 2010 Dec 01; 19(23):4694-704. PubMed ID: 20843825 [Abstract] [Full Text] [Related]
14. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B. Pouw RB, Gómez Delgado I, López Lera A, Rodríguez de Córdoba S, Wouters D, Kuijpers TW, Sánchez-Corral P. Front Immunol; 2018 Dec 01; 9():848. PubMed ID: 29740447 [Abstract] [Full Text] [Related]
15. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation. Valoti E, Alberti M, Tortajada A, Garcia-Fernandez J, Gastoldi S, Besso L, Bresin E, Remuzzi G, Rodriguez de Cordoba S, Noris M. J Am Soc Nephrol; 2015 Jan 01; 26(1):209-19. PubMed ID: 24904082 [Abstract] [Full Text] [Related]
16. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. Venables JP, Strain L, Routledge D, Bourn D, Powell HM, Warwicker P, Diaz-Torres ML, Sampson A, Mead P, Webb M, Pirson Y, Jackson MS, Hughes A, Wood KM, Goodship JA, Goodship TH. PLoS Med; 2006 Oct 01; 3(10):e431. PubMed ID: 17076561 [Abstract] [Full Text] [Related]
17. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration. Schmid-Kubista KE, Tosakulwong N, Wu Y, Ryu E, Hecker LA, Baratz KH, Brown WL, Edwards AO. Invest Ophthalmol Vis Sci; 2009 Nov 01; 50(11):5070-9. PubMed ID: 19553609 [Abstract] [Full Text] [Related]
18. Copy number variation in the complement factor H-related genes and age-related macular degeneration. Kubista KE, Tosakulwong N, Wu Y, Ryu E, Roeder JL, Hecker LA, Baratz KH, Brown WL, Edwards AO. Mol Vis; 2011 Nov 01; 17():2080-92. PubMed ID: 21850184 [Abstract] [Full Text] [Related]
19. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS. Grenda R, Jarmużek W, Rubik J, Prokurat S, Miklaszewska M, Drozdz D, Zachwieja K, Ardissino G, Hofer J. Pediatr Transplant; 2015 Sep 01; 19(6):E130-4. PubMed ID: 26087050 [Abstract] [Full Text] [Related]
20. Autoantibodies in haemolytic uraemic syndrome (HUS). Skerka C, Józsi M, Zipfel PF, Dragon-Durey MA, Fremeaux-Bacchi V. Thromb Haemost; 2009 Feb 01; 101(2):227-32. PubMed ID: 19190803 [Abstract] [Full Text] [Related] Page: [Next] [New Search]